Missouri regulators recall thousands of Cubano and Ostara product packages

The Missouri Division of Cannabis Regulation issued a mandatory recall Wednesday covering thousands of cannabis product packages associated with the Cubano and Ostara brands.

The recall applies to products originating from GF Extraction Lab LLC, operating under manufacturing license MAN000042. According to the Division of Cannabis Regulation recall notice, the products contain cannabinoids produced through chemical modification, conversion, or synthetic derivation.

DCR said the recall was issued in partnership with GF Extraction Lab. Under 19 CSR 100-1.100(4)(P), the division may issue a public recall notice when a cannabis product presents a potential threat to health and safety.

No adverse reactions had been reported to DCR as of the September 2 notice.

The state’s licensee and consumer product list contains over 11,000 package records across 192 licensed facilities, including 188 dispensaries and four manufacturing facilities.

Greenway‘s review of the state file found more than 9,200 records with Ostara product names and 1,900+ Cubano products listed.

The remaining records largely identify bulk distillate, distillate mixes, tablet mixes, and other intermediate materials connected to the recalled products.

   

Affected Ostara products include gummies, vape cartridges, all-in-one vapes, Galaxy Tabs, tinctures, and mystery flavor packs in multiple potencies and varieties. Cubano products listed by the state include distillate-infused pre-ground flower and vape cartridges in numerous cultivars and product varieties.

Because the recall is tied to specific package tags, patients and consumers should compare the package tag on any Cubano or Ostara product they possess with the state’s complete recall list rather than relying on a product name alone.

DCR has advised patients and consumers who purchased a recalled product to stop using it. Unused products may be discarded or returned to the dispensary where they were purchased.

Returned products will not count toward a medical patient’s purchase limit. Consumers seeking information about a return should contact the dispensary where the product was purchased.

Anyone experiencing a life-threatening reaction should seek immediate medical attention. Other adverse reactions may be reported to DCR through the state’s complaint form or by emailing CannabisComplaints@health.mo.gov.

DCR maintains its complete list of current and archived recalls on the division’s product recall page.